Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Patch Clamp

Patch Clamp

Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...

Rise of Liquid in a Capillary Tube

Rise of Liquid in a Capillary Tube

When very thin cylindrical tubes, called capillaries, are dipped in a liquid, the liquid rises or falls in the tube compared to the surrounding liquid. This phenomenon is called capillary action. Capillary action occurs due to the combination of two opposing forces: the cohesive forces of the liquid, which cause it to stick to itself and form a rounded shape, and the adhesive forces between the liquid and the walls of the container, which cause the liquid to be attracted to the container walls.

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Age differences in the impact of dietary salt on metabolism, blood pressure and cognitive function in male rats.

Food & function·2023

Same author

Design, synthesis, and anticancer evaluation of arylurea derivatives as potent and selective type II irreversible covalent FGFR4 inhibitors.

Bioorganic & medicinal chemistry·2023

Same author

Two <i>Cladosporium</i> Fungi with Opposite Functions to the Chinese White Wax Scale Insect Have Different Genome Characters.

Journal of fungi (Basel, Switzerland)·2022

Same author

Design, synthesis and anticancer evaluation of 3-methyl-1H-indazole derivatives as novel selective bromodomain-containing protein 4 inhibitors.

Bioorganic & medicinal chemistry·2022

Same author

Discovery of 4,6-Disubstituted Pyrimidine Derivatives as Novel Dual VEGFR2/FGFR1 Inhibitors.

Chemistry & biodiversity·2021

Same author

Discovery of 4-amino-1H-pyrazolo[3,4-d]pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors.

Bioorganic & medicinal chemistry·2020

Search research articles

Related Experiment Video

Updated: Aug 16, 2025

Using Flexible Gold-Titanium Reaction Cells to Simulate Pressure-Dependent Microbial Activity in the Context of Subsurface Biomining

Using Flexible Gold-Titanium Reaction Cells to Simulate Pressure-Dependent Microbial Activity in the Context of Subsurface Biomining

Published on: October 5, 2019

PROTACS: A technology with a gold rush-like atmosphere.

Yu-Wei Wang¹, Li Lan¹, Min Wang¹

¹Jiangsu Key Laboratory of Drug Design & Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, 210009, PR China.

European Journal of Medicinal Chemistry

|December 25, 2022

Summary

Proteolysis targeting chimera (PROTAC) technology offers a novel therapeutic approach for diseases caused by malfunctioning proteins. This catalytic method hijacks the cell's natural protein degradation system, outperforming traditional inhibitors.

Keywords:

E3 ligases PROTACs Protein degradation

More Related Videos

Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis

Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis

Published on: March 7, 2018

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

Published on: May 25, 2015

Related Experiment Videos

Last Updated: Aug 16, 2025

Using Flexible Gold-Titanium Reaction Cells to Simulate Pressure-Dependent Microbial Activity in the Context of Subsurface Biomining

Using Flexible Gold-Titanium Reaction Cells to Simulate Pressure-Dependent Microbial Activity in the Context of Subsurface Biomining

Published on: October 5, 2019

Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis

Rapid Nanoprobe Signal Enhancement by In Situ Gold Nanoparticle Synthesis

Published on: March 7, 2018

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

qPCRTag Analysis - A High Throughput, Real Time PCR Assay for Sc2.0 Genotyping

Published on: May 25, 2015

Area of Science:

Biochemistry
Molecular Biology
Drug Discovery

Background:

Abnormally expressed or malfunctioning proteins can cause cellular damage and disease.
Conventional small molecule inhibitors have limitations in treating such diseases.
Proteolysis targeting chimera (PROTAC) technology presents a promising alternative therapeutic strategy.

Purpose of the Study:

To review the historical development of PROTAC technology from 2001 to 2022.
To categorize PROTACs based on their target proteins.
To discuss the applications of PROTACs in disease treatment and fundamental biology.

Main Methods:

Review of significant milestones in PROTAC technology development.
Categorization of PROTACs by their targeted proteins.
Discussion of PROTAC applications in disease and biological research.

Main Results:

PROTACs are heterobifunctional molecules with catalytic properties, distinct from occupancy-driven inhibitors.
PROTACs induce target protein ubiquitination and proteasomal degradation.
The paper provides a comprehensive overview of PROTAC evolution and applications.

Conclusions:

PROTAC technology represents a significant advancement in therapeutic strategies for protein-related diseases.
PROTACs offer a catalytic and efficient mechanism for targeted protein degradation.
The continued development and application of PROTACs hold great potential for medicine and biology.